Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
TRANSTHERA-B Opens Up 15% to Hit New Highs, Surpassing SINO BIOPHARM, CSPC PHARMA in Mkt Cap w/ 35x Surge in Less Than 3 Mths Since Debut
Recommend 37 Positive 60 Negative 37 |
||||
|
||||
|
TRANSTHERA-B (02617.HK), a Chinese biopharmaceutical company that has been soaring in recent days, opened 15% higher today (16th) at another new high of HKD477.2, with a pre-market trading volume of 25,500 shares, involving HKD12.1686 million. TRANSTHERA-B was included in the list of securities eligible for Southbound Stock Connect last Monday (8th). It was listed on June 23 at HKD13.15, raising a net amount of HKD161 million. Based on its current price, its stock price is 35.2 times higher than its listing price in less than three months since its debut. TRANSTHERA-B's latest market cap exceeds HKD189 billion, surpassing blue-chip stocks SINO BIOPHARM (01177.HK) with a market cap of over HKD164 billion and CSPC PHARMA (01093.HK) with about HKD123.7 billion, but below HANSOH PHARMA (03692.HK) with about HKD220.6 billion. AAStocks Financial News |
||||
Copied to Clipboard
 |
||||
